Alternative forms of the BCR-ABL oncogene have quantitatively different potencies for stimulation of immature lymphoid cells.

Podobne zapisy

• Differences in oncogenic potency but not target cell specificity distinguish the two forms of the BCR/ABL oncogene.
  od: Kelliher, M, i wsp.
  Wydane: (1991)
• In vitro transformation of immature hematopoietic cells by the P210 BCR/ABL oncogene product of the Philadelphia chromosome.
  od: McLaughlin, J, i wsp.
  Wydane: (1987)
• Selective transformation of primitive lymphoid cells by the BCR/ABL oncogene expressed in long-term lymphoid or myeloid cultures.
  od: Young, J C, i wsp.
  Wydane: (1988)
• Sustained suppression of Bcr-Abl-driven lymphoid leukemia by microRNA mimics
  od: McLaughlin, Jami, i wsp.
  Wydane: (2007)
• Clonal lymphoid progenitor cell lines expressing the BCR/ABL oncogene retain full differentiative function.
  od: Scherle, P A, i wsp.
  Wydane: (1990)